Irbesartan tablets

Irbesartan tablets

Form: Tablets

Strength: 75 mg, 150 mg, 300 mg

Reference Brands: Avapro(Us & EU)

Category: Hypertension

Irbesartan tablets, marketed as Avapro, are approved in the US by the FDA and in the EU via EMA for hypertension and diabetic nephropathy. Regulatory approval requires a detailed dossier, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical trial and quality information, while the EMA verifies compliance with regional safety, efficacy, and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional compliance supports timely approval, safe medication use, and global availability of irbesartan tablets, helping manage hypertension and protect renal function worldwide effectively.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Antithymocyte Globulin (ATG) powder for injection

Strength: 250mg/5ml

Form: Lyophilized powder

Reference Brands: Thymoglobulin(US & EU)

View Details Get Enquiry
Hydralazine tablets

Strength: 10 mg, 25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Apresoline(US & Eu)

View Details Get Enquiry
Methyldopa tablets

Strength: 250 mg, 500 mg, and 750 mg

Form: Tablets

Reference Brands: Aldomet(US)

View Details Get Enquiry
Clonidine Patch

Strength: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours

Form: transdermal patch

Reference Brands: Catapres(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.